105 related articles for article (PubMed ID: 24703244)
21. mTOR kinase inhibitors as a treatment strategy in hematological malignancies.
Grzybowska-Izydorczyk O; Smolewski P
Future Med Chem; 2012 Mar; 4(4):487-504. PubMed ID: 22416776
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance.
Lucafò M; Bravin V; Tommasini A; Martelossi S; Rabach I; Ventura A; Decorti G; De Iudicibus S
Clin Exp Pharmacol Physiol; 2016 Jun; 43(6):602-5. PubMed ID: 27001230
[TBL] [Abstract][Full Text] [Related]
23. Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma.
Yazbeck VY; Buglio D; Georgakis GV; Li Y; Iwado E; Romaguera JE; Kondo S; Younes A
Exp Hematol; 2008 Apr; 36(4):443-50. PubMed ID: 18343280
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
25. mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells.
Kawada J; Ito Y; Iwata S; Suzuki M; Kawano Y; Kanazawa T; Siddiquey MN; Kimura H
Clin Cancer Res; 2014 Nov; 20(21):5412-22. PubMed ID: 25208880
[TBL] [Abstract][Full Text] [Related]
26. The role of mTOR inhibitors in the inhibition of growth and cortisol secretion in human adrenocortical carcinoma cells.
De Martino MC; van Koetsveld PM; Feelders RA; Sprij-Mooij D; Waaijers M; Lamberts SW; de Herder WW; Colao A; Pivonello R; Hofland LJ
Endocr Relat Cancer; 2012 Jun; 19(3):351-64. PubMed ID: 22420007
[TBL] [Abstract][Full Text] [Related]
27. Mammalian target of rapamycin inhibitor rapamycin enhances anti-leukemia effect of imatinib on Ph+ acute lymphoblastic leukemia cells.
Yang X; He G; Gong Y; Zheng B; Shi F; Shi R; Yang X
Eur J Haematol; 2014 Feb; 92(2):111-20. PubMed ID: 24112092
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines.
Pickard MR; Mourtada-Maarabouni M; Williams GT
Biochim Biophys Acta; 2013 Oct; 1832(10):1613-23. PubMed ID: 23676682
[TBL] [Abstract][Full Text] [Related]
29. Sorafenib inhibits cell migration and stroma-mediated bortezomib resistance by interfering B-cell receptor signaling and protein translation in mantle cell lymphoma.
Xargay-Torrent S; López-Guerra M; Montraveta A; Saborit-Villarroya I; Rosich L; Navarro A; Pérez-Galán P; Roué G; Campo E; Colomer D
Clin Cancer Res; 2013 Feb; 19(3):586-97. PubMed ID: 23231952
[TBL] [Abstract][Full Text] [Related]
30. Targeting mantle cell lymphoma metabolism and survival through simultaneous blockade of mTOR and nuclear transporter exportin-1.
Sekihara K; Saitoh K; Han L; Ciurea S; Yamamoto S; Kikkawa M; Kazuno S; Taka H; Kaga N; Arai H; Miida T; Andreeff M; Konopleva M; Tabe Y
Oncotarget; 2017 May; 8(21):34552-34564. PubMed ID: 28388555
[TBL] [Abstract][Full Text] [Related]
31. Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1.
Zang C; Eucker J; Liu H; Müller A; Possinger K; Scholz CW
Cancer Lett; 2013 Oct; 339(2):288-97. PubMed ID: 23200668
[TBL] [Abstract][Full Text] [Related]
32. Growth arrest on inhibition of nonsense-mediated decay is mediated by noncoding RNA GAS5.
Mourtada-Maarabouni M; Williams GT
Biomed Res Int; 2013; 2013():358015. PubMed ID: 24319682
[TBL] [Abstract][Full Text] [Related]
33. Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells.
Xu RH; Pelicano H; Zhang H; Giles FJ; Keating MJ; Huang P
Leukemia; 2005 Dec; 19(12):2153-8. PubMed ID: 16193082
[TBL] [Abstract][Full Text] [Related]
34. MTOR inhibition attenuates DNA damage and apoptosis through autophagy-mediated suppression of CREB1.
Wang Y; Hu Z; Liu Z; Chen R; Peng H; Guo J; Chen X; Zhang H
Autophagy; 2013 Dec; 9(12):2069-86. PubMed ID: 24189100
[TBL] [Abstract][Full Text] [Related]
35. Plasma Long Non-Coding RNA (lncRNA) GAS5 is a New Biomarker for Coronary Artery Disease.
Yin Q; Wu A; Liu M
Med Sci Monit; 2017 Dec; 23():6042-6048. PubMed ID: 29267258
[TBL] [Abstract][Full Text] [Related]
36. An androgen reduced transcript of LncRNA GAS5 promoted prostate cancer proliferation.
Zhang Y; Su X; Kong Z; Fu F; Zhang P; Wang D; Wu H; Wan X; Li Y
PLoS One; 2017; 12(8):e0182305. PubMed ID: 28771526
[TBL] [Abstract][Full Text] [Related]
37. Silencing
Li J; Zhang J; Jin L; Deng H; Wu J
Anticancer Res; 2018 Jun; 38(6):3427-3434. PubMed ID: 29848693
[TBL] [Abstract][Full Text] [Related]
38. lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer.
Liu Y; Zhao J; Zhang W; Gan J; Hu C; Huang G; Zhang Y
Sci Rep; 2015 May; 5():10159. PubMed ID: 25959498
[TBL] [Abstract][Full Text] [Related]
39. 2-O-Methylmagnolol upregulates the long non-coding RNA, GAS5, and enhances apoptosis in skin cancer cells.
Wang TH; Chan CW; Fang JY; Shih YM; Liu YW; Wang TV; Chen CY
Cell Death Dis; 2017 Mar; 8(3):e2638. PubMed ID: 28252643
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA growth arrest-specific 5 promotes proliferation and survival of female germline stem cells in vitro.
Wang J; Gong X; Tian GG; Hou C; Zhu X; Pei X; Wang Y; Wu J
Gene; 2018 May; 653():14-21. PubMed ID: 29428796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
